Skip to main navigation Skip to search Skip to main content

The Brucella effector BspL targets the ER-associated degradation (ERAD) pathway and delays bacterial egress from infected cells

  • Jean-Baptiste Luizet
  • , Julie Raymond
  • , Thais Lourdes Santos Lacerda
  • , Emeline BARBIEUX
  • , Stanimir Kambarev
  • , Magali Bonici
  • , Frédérique Lembo
  • , KEVIN WILLEMART
  • , Jean-Paul Borg
  • , Jean Celli
  • , Francine C. A. Gérard
  • , Eric MURAILLE
  • , Jean-Pierre Gorvel
  • , Suzana P Salcedo

Research output: Contribution to journalArticlepeer-review

Abstract

Perturbation of the endoplasmic reticulum (ER), a central organelle of the cell, can have critical consequences for cellular homeostasis. An elaborate surveillance system known as ER quality control ensures that cells can respond and adapt to stress via the unfolded protein response (UPR) and that only correctly assembled proteins reach their destination. Interestingly, several bacterial pathogens hijack the ER to establish an infection. However, it remains poorly understood how bacterial pathogens exploit ER quality-control functions to complete their intracellular cycle. Brucella spp. replicate extensively within an ER-derived niche, which evolves into specialized vacuoles suited for exit from infected cells. Here we present Brucella-secreted protein L (BspL), a Brucella abortus effector that interacts with Herp, a central component of the ERassociated degradation (ERAD) machinery. We found that BspL enhances ERAD at the late stages of the infection. BspL targeting of Herp and ERAD allows tight control of the kinetics of autophagic Brucella-containing vacuole formation, delaying the last step of its intracellular cycle and cell-to-cell spread. This study highlights a mechanism by which a bacterial pathogen hijacks ERAD components for fine regulation of its intracellular trafficking.

Original languageEnglish
Article numbere2105324118
JournalProceedings of the National Academy of Sciences of the United States of America
Volume118
Issue number32
DOIs
Publication statusPublished - 10 Aug 2021

Funding

We thank Linda Hendershot (St. Jude's Children's Research Hospital) for sending us the pcDNA-TCR\u03B1 and for all the help with setting up the endoplasmic reticulum-associated degradation assay and discussion of the results; Thomas Rutkowski (University of Iowa) for the cDNA encoding the Null Hong Kong mutant of \u03B11-antitrypsin; Ren\u00E9e Tsolis (University of California, Davis) for help constructing TEM1-VceC and HA-VceC; Thomas Henry (Centre International de Recherche en Infectologie, Lyon, France) for the immortalized cell line of bone marrow-derived macrophages; Steve Garvis, Amandine Blanco, and Arthur Louche for the critical reading of the manuscript; and Peter Cresswell and Susan Mitchell (Yale University School of Medicine) for sending us the endoplasmic reticulum-associated degradation reporter cell line and all the advice despite all the challenges imposed by the pandemic. All microscopy imaging was carried out at the PLATIM microscopy facility. The two-hybrid screening was hosted by the Marseille Proteomics platform (J.-P.B. and F.L.) supported by Institut Paoli- Calmettes, Infrastructures Biologie Sant\u00E9 et Agronomie, Aix-Marseille University, Cancerop\u00F4le PACA, and the R\u00E9gion Sud Provence-Alpes-C\u00F4te d'Azur. J.-P.B. is a scholar of Institut Universitaire de France. This work was funded by the ERA-Net Pathogenomics CELLPATH Grant Agriculture and Natural Resources (ANR) 2010-PATH-006, the FINOVI foundation under a Young Researcher Starting grant, ANR NUCPATH Grant ANR-15-CE15-0011, and the ANR charm-Ed Grant ANR-18-CE15-0003 (all obtained by S.P.S.). J.-B.L. was supported by a doctoral contract from the R\u00E9gion Rh\u00F4nes-Alpes ARC1 Sant\u00E9. An INSERM staff scientist contract supports S.P.S. The original submission of this manuscript was published on BiorXiv and is part of the PhD thesis manuscript of J.-B.L., \"Host Cell modulation by Brucella effectors,\" Universit\u00E9 de Lyon, France, 2019. ACKNOWLEDGMENTS. We thank Linda Hendershot (St. Jude\u2019s Children\u2019s Research Hospital) for sending us the pcDNA-TCR\u03B1 and for all the help with setting up the endoplasmic reticulum-associated degradation assay and discussion of the results; Thomas Rutkowski (University of Iowa) for the cDNA encoding the Null Hong Kong mutant of \u03B11-antitrypsin; Ren\u00E9e Tsolis (University of California, Davis) for help constructing TEM1-VceC and HA-VceC; Thomas Henry (Centre International de Recherche en Infectologie, Lyon, France) for the immortalized cell line of bone marrow-derived macrophages; Steve Garvis, Amandine Blanco, and Arthur Louche for the critical reading of the manuscript; and Peter Cresswell and Susan Mitchell (Yale University School of Medicine) for sending us the endoplasmic reticulum-associated degradation reporter cell line and all the advice despite all the challenges imposed by the pandemic. All microscopy imaging was carried out at the PLATIM microscopy facility. The two-hybrid screening was hosted by the Marseille Proteomics platform (J.-P.B. and F.L.) supported by Institut Paoli-Calmettes, Infrastructures Biologie Sant\u00E9 et Agronomie, Aix-Marseille University, Cancerop\u00F4le PACA, and the R\u00E9gion Sud Provence-Alpes-C\u00F4te d\u2019Azur. J.-P.B. is a scholar of Institut Universitaire de France. This work was funded by the ERA-Net Pathogenomics CELLPATH Grant Agriculture and Natural Resources (ANR) 2010-PATH-006, the FINOVI foundation under a Young Researcher Starting grant, ANR NUCPATH Grant ANR-15-CE15-0011, and the ANR charm-Ed Grant ANR-18-CE15-0003 (all obtained by S.P.S.). J.-B.L. was supported by a doctoral contract from the R\u00E9gion Rh\u00F4nes-Alpes ARC1 Sant\u00E9. An INSERM staff scientist contract supports S.P.S. The original submission of this manuscript was published on BiorXiv and is part of the PhD thesis manuscript of J.-B.L., \u201CHost Cell modulation by Brucella effectors,\u201D Universit\u00E9 de Lyon, France, 2019.

FundersFunder number
Institut National de la Santé et de la Recherche Médicale
Institut Paoli-Calmettes
Aix-Marseille Université
Institut Paoli- Calmettes
Université de Lyon
Institut Universitaire de France
Infrastructures en Biologie Santé et Agronomie
University of Iowa
Yale University
Thomas Rutkowski
Région Rhônes-Alpes ARC1 Santé
Conseil Régional Provence-Alpes-Côte d'Azur2010-PATH-006
Fondation Innovations en InfectiologieANR-18-CE15-0003
Agence Nationale de la RechercheANR-15-CE15-0011

    Keywords

    • Brucella
    • ERAD
    • Herp
    • Trafficking

    Fingerprint

    Dive into the research topics of 'The Brucella effector BspL targets the ER-associated degradation (ERAD) pathway and delays bacterial egress from infected cells'. Together they form a unique fingerprint.

    Cite this